Skip to main content
NewslettersWatchlist

Theratechnologies(TH-T)
TSX

Today's Change
Real-Time Last Update

Will This Dual-Listed Bio-Pharma Catch New Year Action?

AllPennyStocks.com - AllPennyStocks.com - Tue Jan 2, 8:14AM CST

This pharmaceutical company is addressing the medical needs of patients with HIV and may be starting the new year off right. Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX)is a biopharmaceutical company focused on the development and commercialization of innovative therapies, announced in a press release today the filing of a supplemental Biologics License Application for an intramuscular method of administration for the maintenance dose of Trogarzo ® (ibalizumab-uiyk) to the United States Food and Drug Administration for review. 

The drug is offered in the United States in combination with other antiretrovirals and is indicated for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current ARV regimen. The firm offers its product under the brand name EGRIFTA, an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. 


Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

More from The Globe

market news
At midday: TSX struggles for direction as investors prepare for U.S. Fed decision
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 26.
market news
The close: Major North American indexes rise as megacap tech stocks rally
A trader works on the floor at the New York Stock Exchange (NYSE) on April 25.
advisor etfs
Why this money manager is venturing back into emerging markets and adding more U.S. tech
Illustration of Andrew Pyle for The Mover. Nov. 5, 2022. Illustration by Joel Kimmel
globe investor
How a Canadian pirate-clad pastor helped ignite Trump Media’s market frenzy
Former President Donald Trump sits in Manhattan Criminal Court in New York, Thursday, April 25.
report on business
Activist investor targets Dye & Durham’s ‘underperformance and strategic missteps’ in letter to shareholders
Dye & Durham Ltd. says it has launched a strategic review of its non-core assets in an effort to reduce its debt. The logo for Dye & Durham Ltd. is shown in this undated handout photo. THE CANADIAN PRESS/HO
market news
The close: U.S. stocks fall as GDP report spreads rate-cut gloom; Alphabet surges 15% in post market
Traders work on the floor of the New York Stock Exchange shortly after the opening bell, Wednesday, April 24.
report on business
Fiera Capital’s largest shareholder looks to sell stake in company
Jean-Guy Desjardins, global CEO and founder of Fire Capital posses for a portrait at Fiera Capital, in Montreal on Monday, January 8, 2024. Evan Buhler/The Globe and Mail�
market news
The close: S&P 500 higher as markets weigh rising bond yields and upbeat U.S. earnings; TSX lower as rails slide
The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto in January of 2019.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).